It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

A systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...

The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn. "Make ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

The weight of being a Hollywood star can take a toll on a person’s weight.In an industry obsessed with physical appearance, a ...

In the GLP-1 weight loss market, it's largely been a two-horse race between Eli Lilly and Novo Nordisk (NYSE: NVO). The two ...

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.

There is growing competition in the diaper market with Chinese brands entering the US, creating pricing pressure.s. Barclays ...

In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...